Skip to content
Nonprofiteer
← PARENTERAL DRUG ASSOCIATION INC

Form 990 for tax year 2024

Filed by PARENTERAL DRUG ASSOCIATION INC.

Totals

Total revenue
$15,336,776
Total expenses
$15,667,738
Contributions and grants received
$1,393,400
Grants paid
$5,000
Program service revenue
$12,683,688
Investment income
$335,382
Other revenue
$924,306
Total assets, end of year
$18,736,014
Total liabilities, end of year
$12,989,705
Net assets or fund balances, end of year
$5,746,309
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $1,124,620

  • 1f · All other contributions, gifts and grants

    $268,780

  • 1g · Noncash contributions included above

    $260,780

  • 2a · Program service revenue: MEETINGS, EXHIBITS, & CONFERENCES

    total $8,300,956 · related or exempt $8,300,956

  • 2b · Program service revenue: MEMBERSHIP DUES

    total $2,318,293 · related or exempt $2,318,293

  • 2c · Program service revenue: EDUCATION

    total $1,940,933 · related or exempt $1,940,933

  • 2d · Program service revenue: JOURNAL SUBSCRIPTION

    total $123,506 · related or exempt $123,506

  • 3 · Investment income

    total $287,309 · excluded $287,309

  • 5 · Royalties

    total $112,876 · excluded $112,876

  • 7a · Gross sales of assets other than inventory

    securities $48,073

  • 7b · Less cost or other basis and sales expenses

    securities $0

  • 7c · Gain or loss

    securities $48,073

  • 7d · Net gain or loss

    total $48,073 · excluded $48,073

  • 10a · Gross sales of inventory

    $741,323

  • 10b · Cost of goods sold

    $188,707

  • 10c · Net income from sales of inventory

    total $552,616 · related or exempt $552,616

  • 11a · Other revenue: ADVERTISING

    total $218,208 · unrelated business $218,208

  • 11b · Other revenue: MISCELLANEOUS INCOME

    total $23,439 · excluded $23,439

  • 11c · Other revenue: CANCELLATION FEES

    total $9,260 · excluded $9,260

  • 11d · All other revenue

    total $7,907 · excluded $7,907

  • 11e · Other revenue, total

    $258,814

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $5,000

  • 5 · Compensation of officers, directors and key employees

    total $1,644,257

  • 7 · Other salaries and wages

    total $3,492,804

  • 8 · Pension plan contributions

    total $223,648

  • 9 · Other employee benefits

    total $563,032

  • 10 · Payroll taxes

    total $342,248

  • 11b · Fees: legal

    total $16,545

  • 11c · Fees: accounting

    total $61,920

  • 11f · Fees: investment management

    total $66,503

  • 11g · Fees: other

    total $3,163,840

  • 12 · Advertising and promotion

    total $785,664

  • 13 · Office expenses

    total $877,271

  • 14 · Information technology

    total $123,763

  • 16 · Occupancy

    total $92,873

  • 17 · Travel

    total $582,015

  • 19 · Conferences, conventions and meetings

    total $1,110,701

  • 20 · Interest

    total $131,907

  • 22 · Depreciation, depletion and amortization

    total $489,137

  • 23 · Insurance

    total $69,738

  • 24a · Other expenses: EVENT EXPENSES

    total $1,739,263

  • 24b · Other expenses: DUES AND SUBSCRIPTIONS

    total $38,731

  • 24c · Other expenses: INTERNATIONAL TAX

    total $21,752

  • 24d · Other expenses: SOFTWARE DEVELOPMENT

    total $15,240

  • 24e · All other expenses

    total $9,886

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $348,716 · end of year $280,891

  • 2 · Savings and temporary cash investments

    beginning of year $846,963 · end of year $518

  • 3 · Pledges and grants receivable

    end of year $346,030

  • 4 · Accounts receivable

    beginning of year $298,655 · end of year $160,601

  • 8 · Inventories for sale or use

    beginning of year $24,200 · end of year $24,006

  • 9 · Prepaid expenses and deferred charges

    beginning of year $263,512 · end of year $309,995

  • 10a · Land, buildings and equipment: cost or other basis

    $8,609,115

  • 10b · Land, buildings and equipment: accumulated depreciation

    $6,776,707

  • 10c · Land, buildings and equipment, net

    beginning of year $2,097,384 · end of year $1,832,408

  • 11 · Investments: publicly traded securities

    beginning of year $8,487,168 · end of year $8,872,064

  • 14 · Intangible assets

    beginning of year $6,092,189 · end of year $5,333,542

  • 15 · Other assets

    beginning of year $1,284,102 · end of year $1,575,959

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,971,976 · end of year $2,248,099

  • 19 · Deferred revenue

    beginning of year $1,666,930 · end of year $1,749,728

  • 24 · Unsecured notes and loans payable

    beginning of year $2,399,748 · end of year $1,632,277

  • 25 · Other liabilities

    beginning of year $8,232,585 · end of year $7,359,601

  • 27 · Net assets without donor restrictions

    beginning of year $5,471,650 · end of year $5,746,309

Mission and programs · 2024

Mission

TO DEVELOP SCIENTIFICALLY SOUND, PRACTICAL TECHNICAL INFORMATION AND RESOURCES TO ADVANCE SCIENCE AND REGULATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY THROUGH THE EXPERTISE OF OUR GLOBAL MEMBERSHIP.

Activities or mission (Part I)

TO BE THE FOREMOST GLOBAL PROVIDER OF SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION AND EDUCATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMMUNITY.

  • PROGRAMS & MEETINGS-EDUCATE MEMBERS AND NON-MEMBERS BY TEACHING DEVELOPMENTS IN MANUFACTURING AND QUALITY CONTROL FOR PRIMARY STERILE PRODUCT DEVELOPMENTS.

  • TRAINING & RESEARCH INSTITUE (TRI)EDUCATIONAL COURSES - TECHNICAL TRAINING FOR SCIENTISTS IN THE PHARMACEUTICAL AREAS OF MANUFACTURING, DEVELOPMENT AND QUALITY CONTROL. TRAINING - TRAIN MEMBERS AND NON-MEMBERS TO BASIC MANUFACTURING TECHNIQUES CENTERED AROUND GMP GUIDELINES.

  • MEMBERSHIP & CHAPTER SERVICES-PROVIDE THE LATEST GUIDELINES FOCUSING ON TECHNOLOGY INFORMATION ON MANUFACTURING, TECHNICAL REPORTS, AND QUALITY CONTROL.

  • PUBLICATION SALES- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION.SALES, EXHIBIT & SPONSORSHIP, ADVERTISING- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Anil Sawant PhD

    CHAIR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Melissa Seymour MBA

    CHAIR-ELLECT

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Susan Schniepp

    IMMEDIATE PAST CHAIR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Emma Ramnarine

    TREASURER

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Bettine Boltres PhD

    SECRETARY

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Lisa Bennett

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Christiana Campa

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Andrew Chang

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Cylia Chen Qoi

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Mirko Gabriele

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Marc Glogovsky

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Andrew Hopkins

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Stephan Krause PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Ivy Louis

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Amy McDaniel

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Brigitte Reutter-Haerle

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Osamu Skirokizawa

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related
  • Glenn Wright

    CEO

    Total calculated
    $473,512
    From this org
    $426,542
    From related orgs
    $0
    Other
    $46,970
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $366,827
    Bonus
    $52,500
    Other
    $7,215
    Deferred
    $46,000
    Nontaxable benefits
    $970
    Filer's total
    $473,512
  • Jennifer Bell

    CFO

    Total calculated
    $293,457
    From this org
    $239,928
    From related orgs
    $0
    Other
    $53,529
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $198,603
    Bonus
    $38,899
    Other
    $2,426
    Deferred
    $46,000
    Nontaxable benefits
    $7,529
    Filer's total
    $293,457
  • David Hall

    VP EXHIBITS

    Total calculated
    $309,320
    From this org
    $243,228
    From related orgs
    $0
    Other
    $66,092
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $209,696
    Bonus
    $31,012
    Other
    $2,520
    Deferred
    $46,000
    Nontaxable benefits
    $20,092
    Filer's total
    $309,320
  • David Talmage

    VP EDUCATION

    Total calculated
    $289,815
    From this org
    $217,711
    From related orgs
    $0
    Other
    $72,104
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $188,260
    Bonus
    $27,944
    Other
    $1,507
    Deferred
    $58,267
    Nontaxable benefits
    $13,837
    Filer's total
    $289,815
  • Molly O'Neill

    VP PROGRAMS

    Total calculated
    $278,153
    From this org
    $216,974
    From related orgs
    $0
    Other
    $61,179
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $187,702
    Bonus
    $27,864
    Other
    $1,408
    Deferred
    $47,400
    Nontaxable benefits
    $13,779
    Filer's total
    $278,153
  • Walter Morris III

    SR DIRECTOR PUBLICATIONS

    Total calculated
    $210,008
    From this org
    $174,796
    From related orgs
    $0
    Other
    $35,212
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $152,568
    Bonus
    $21,468
    Other
    $760
    Deferred
    $27,244
    Nontaxable benefits
    $7,968
    Filer's total
    $210,008
  • Alethea Tavares

    CHIEF OF STAFF

    Total calculated
    $190,581
    From this org
    $162,887
    From related orgs
    $0
    Other
    $27,694
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $154,000
    Bonus
    $8,700
    Other
    $187
    Deferred
    $20,295
    Nontaxable benefits
    $7,399
    Filer's total
    $190,581
  • Joshua Eaton

    SR DIRECTOR SRA

    Total calculated
    $200,066
    From this org
    $161,218
    From related orgs
    $0
    Other
    $38,848
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $143,529
    Bonus
    $17,433
    Other
    $256
    Deferred
    $25,140
    Nontaxable benefits
    $13,708
    Filer's total
    $200,066
  • Michael Porter

    SR DIRECTOR, EDUCATION

    Total calculated
    $156,958
    From this org
    $140,141
    From related orgs
    $0
    Other
    $16,817
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $139,641
    Bonus
    $500
    Other
    $0
    Deferred
    $16,817
    Nontaxable benefits
    $0
    Filer's total
    $156,958
  • Faramarz Kolivand

    SR WEB DEVELOPER

    Total calculated
    $177,541
    From this org
    $143,243
    From related orgs
    $0
    Other
    $34,298
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $127,956
    Bonus
    $15,156
    Other
    $131
    Deferred
    $20,485
    Nontaxable benefits
    $13,813
    Filer's total
    $177,541

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Health or social club dues or initiation fees
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

The filer's explanations (Part III)

PART I, LINE 1A:
PDA PAYS 80% OF THE COST FOR USE OF A HEALTH CLUB (GYM) FOR ALL OF ITS EMPLOYEES.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • FOUNDATION FOR PHARMACEUTICAL EDUCATION TRAINING AND RESEARCH

    501(C)(3) · SUPPORT EDUCATION, TRAINING AND RESEARCH IN THE PHARMACEUTICAL · DC · controlled entity

    Directly controlled by PARENTERAL DRUG ASSOCIATION INC

  • PDA EUROPE

    NONPROFIT GERMAN · SHARES PDA MISSION AS STATED ON PAGE 1 OF THIS FORM 990 · GM · controlled entity

    Directly controlled by PARENTERAL DRUG ASSOCIATION INC

Provenance

Return type
form_990
Tax year
2024
Filed
14 November 2025
IRS schema version
2024v5.2
Source object
202503189349306150

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.